KRAS and pancreatic ductal adenocarcinoma: Barceló et al. [32] reported that HNRNPA2B1 acts as a regulator of KRAS-dependent tumourigenesis through the critical pancreatic ductal adenocarcinoma cell signalling pathway PI3K/AKT.